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ABSTRACT A cDNA library was prepared from a termi-
nal deoxynucleotidyltransferase-containing thymoma in the X
phage vector Xgtll. By screening plaques with anti-terminal
transferase antibody, positive clones were identified of which
some had 3..galactosidase-cDNA fusion proteins identifiable
after electrophoretic fractidhatioh by immunoblotting with
anti-terminal transferase antibody. The iredosinant class of
cross-hybridizing clones was determined to represent cDNA
for terminal transferase by showing that one representative
clone hybridized to a 2200-nucleotide mRNA in close-matched
enzyftae-positive but not to enzyme-negative cells and that the
cDNA selected a mRNA that translated to give a protein of the
size and antigenic characteristics of terminal transferase. Only
a small amount of genomic DNA hybridized to the longest
available clone, indicating that the sequence is virtually unique
in the mouse genome.
Terminal deoxynucleotidyltransferase (TdT) is a unique
DNA polymerase that without template direction catalyzes
the addition of deoxyribonucleotides onto the 3'-hydroxyl
ends of DNA primers (1-3). It is present in the immature
fraction of thymocytes (4-7), in a small fraction of bone mar-
row cells (5, 8), in transformed pre-B- and pre-T-cell lines (9,
10), and in leukemic cells (6, 11). The enzyme purified by the
method of Yoneda and Bollum (12) and Chang and Bollum
(13) is a dimer of Mr 26,000 and Mr 8,000 chains. This struc-
ture is, however, an artifactual result of proteolytic cleavage
during the purification. The enzyme is synthesized as a sin-
gle chain of Mr 58,000 in mice and Mr 55,000-60,000 in hu-
mans (14-18).
The function of TdT is not fully established. It was sug-
gested that the enzyme might be responsible for somatic
point mutation of immunoglobulin genes (19), but it now ap-
pears that somatic point mutation occurs late in B-lympho-
cyte maturation, when cells no longer contain TdT (20, 21).
A recent proposal that TdT might be responsible for insert-
ing nucleotides (N regions) at VH-D and D-JH (22) junctions
(junctions of heavy chain variable-diversity and diversity-
joining region genes) has received experimental support (un-
published results). N-region insertion in a T-cell receptor
chain may also occur (23) and is possibly a result of the rela-
tively high TdT levels in thymocytes.
We describe here the isolation from a thymoma cell line
cDNA library of a clone that encodes TdT. Because the ami-
no acid sequence ofTdT has not been reported, there was no
nucleic acid probe available for screening recombinants. In-
stead, specific antibodies raised against the purified two-
chain bovine enzyme, which cross-react with the murine en-
zyme, were used to probe a cDNA library constructed in the
Xgtl1 expression system of Young and Davis (24). As well as
providing a cDNA clone with which to characterize TdT,
this work shows the feasibility of cloning ctlNA representa-
tions of rare mRNAs with conventional antibody reagents.
METHODS
Xgtl1 cDNA Library Construction. Double-stranded
cDNA was synthesized from 20 gg of RL 11 poly(A)-con-
taining RNA, protected by reaction with EcoRI methylase,
treated with S1 nuclease to produce blunt ends, and ligated
to EcoRI linkers as described (25). The cDNA was digested
with EcoRI and purified by chromatography on Bio-Gel
A15M in TEN buffer (10 mM Tris, pH 8.0/1 mM
EDTA/0.15 M NaCl). It was then ligated to EcoRI-cut XgtlO
DNA, packaged, and grown on BNN102, an hfl strain of
Escherichia coli in which phages that lack a cDNA insert are
lysogenized (24). Phage that contain cDNA inserts can be
recognized by their clear plaques on BNN102 (25). DNA was
purified from a pool of 3 x 106 independent phage clones,
97% of which contained inserts as judged by their clear
plaque morphology. The cDNA was transferred to the Xgt11
vector by inactivating the XgtlO recombinant DNA by briefly
digesting with BAL-31 exonuclease, digesting with EcoRI,
and ligating to EcoRI-cleaved, phosphatase-treated Xgt11
DNA.
Phage DNA was then packaged and plated on Y1088 (24),
a laciq strain of E. coli that represses transcription of the 8-
galactosidase-cDNA fusion protein. From the resulting
phage, 106 were plated on KM392 E. coli, and the plaques
were transferred to nitrocellulose filters (Schleicher &
Schuell; BA85 0.45 m, 1322 mm).
Antibody Screening of Phage Library and Protein Blotting.
Filters were washed in phosphate-buffered saline/1% bovine
serum albumin/0.1% Nonidet P-40 (NP-40) and probed by
the application of phosphate-buffered saline/1% albu-
min/0.1% NP-40 containing rabbit anti-calf terminal trans-
ferase affinity-purified antibody (P-L Biochemicals; 0.5
/ig/ml) for 12 hr at 40C. After washing, the filters were gently
agitated in albumin/NP-40 containing 0.2 x 106 cptm of 1251_
labeled Staphylococcus aureus protein A (I251-protein A) per
ml for 2 hr at 40C. The filters were washed extensively in
albumin/NP-40 at 40C and exposed to x-ray film for 2 days.
Positive clones were picked from the master plates and puri-
fied through two additional rounds of screening. Several of
the phage inserts were recloned into the EcoRI site of
pBR322 (producing the plasmid used most extensively,
pTdT20).
To examine the f3-galactosidase-cDNA fusion proteins for
immunoreactivity, phage lysogens were derived (24). Lyso-
gens were induced at 450C with or without 2 mM isopropyl-
,B3D-thiogalactopyranoside (iPrSGalp) for 2 hr. Bacteria were
lysed in reducing sample buffer, and the proteins were sepa-
Abbreviations: TdT, terminal deoxynucleotidyltransferase; bp, base
pair(s); iPrSGalp, isopropyl-,3-D-thiogalactopyranoside.
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rated by electrophoresis through 7% NaDodSO4/polyacryl-
amide gels. The separated proteins were transferred to a ni-
trocellulose filter (26) and probed by treatment with 0.5 ,ug of
antibody per ml and 1 x 107 cpm of 1251-protein A as de-
scribed above for antibody screening.
RNA and DNA Filter Hybridization. RNA was prepared
from cells or tissue by the guanidinium thiocyanate proce-
dure (27) and selected for poly(A)-containing RNA by using
an oligo(dT)-cellulose column (Collaborative Research, Wal-
tham, MA; type III). From the poly(A)-selected RNA, 10 ,g
was denatured by heating to 560C in 2.2 M formalde-
hyde/50% formamide and fractionated by electrophoresis
through 1.2% agarose containing 2.2 M formaldehyde. The
fractionated RNA was transferred to nitrocellulose and hy-
bridized to 32P-labeled pTdT20 as described (28).
Genomic DNA (10 ug) was cleaved with restriction en-
zyme and fractionated by electrophoresis through 1.0o agar-
ose. Cloned phage DNA (2 pg) was cleaved and fractionated
on 1.4% agarose. Transfer of the DNA to nitrocellulose and
hybridization with nick-translated plasmid DNA was as de-
scribed (28). Genomic DNA was probed with the purified
cDNA insert from plasmid pOK6, a 1400-base-pair (bp)
cDNA-containing plasmid derived by screening an EL4 thy-
moma cell line cDNA library (29) with the pTdT20 probe.
Filters were exposed with an intensifying screen at -70°C.
In Vitro Translation and Hybrid Selection. From the plas-
mid DNA, 10 gg was spotted onto nitrocellulose filters, de-
natured by exposure to 0.5 M NaOH for 7 min, neutralized in
0.1 M Tris (pH 7.4) followed by 0.15 M Na citrate/1.5 M
NaCl, pH 7.4, for 10 min, and baked in vacuo for 1 hr. Po-
ly(A)-containing RNA (266 yg/ml) from RL& 11 was hybrid-
ized to the filters in 50%o formamide/20 mM piperazine-
N,N'-bis(2-ethanesulfonic acid)/0.2% NaDodSO4/0.6 M
NaCI/0. 1 mg of tRNA per ml at 70°C for 10 min followed by
4 hr at 42°C. The filters were washed in 10 mM Tris, pH
7.6/0.15 M NaCl/1 mM EDTA/0.5% NaDodSO4 at 65°C,
and the RNA was eluted in H20 containing 0.1 ug of tRNA
per ml at 100°C for 1 min. The eluted RNA was ethanol-
precipitated, lyophilized, and dissolved in 10 ,ul of H20. The
RNA was translated in a rabbit reticulocyte lysate system
(Bethesda Research Laboratories) in the presence of 1 ALCi (1
Ci = 37 GBq) of [35S]methionine per ,u. Translated products
were immunoprecipitated with 2 ,ul of antibody or normal
rabbit serum in buffer containing 10 mM sodium phosphate
(pH 7.5), 100 mM sodium chloride, 1% Triton X-100, 0.5%
deoxycholate, and 0.1% NaDodSO4. Immunocomplexes
were collected on S. aureus, eluted by boiling in gel buffer
containing 3% 2-mercaptoethanol, and separated by electro-
phoresis through 7-20% gradient NaDodSO4/polyacrylam-
ide gels.
The anti-TdT antiserum was prepared by injection of two
rabbits with TdT extracted from calf thymus and purified
through the hydroxylapatite step (13, 14). RLY3 cells (30)
were metabolically labeled as described (14), and lysates
were immunoprecipitated as described above.
RESULTS
The radiation-induced BALB/c thymoma cell line RLT11
stably synthesizes TdT (14, 31) and, therefore, was used as a
source of mRNA for the synthesis of a cDNA library. The
cDNA was cloned initially into the EcoRI site of XgtlO be-
cause of this phage's high cloning efficiency (unpublished
observations) and then was transferred into the EcoRI site of
Xgtll. Because the EcoRI site of Xgtll lies in the f3galacto-
sidase gene, the presence of a cDNA insert causes loss of the
blue-plaque phenotype when the phage is grown on lacZ-
bacteria and plated on medium containing 5-bromo-4-chloro-
3-indolyl ,B-D-galactoside (24). Of the Xgtll plaques, 93%
were colorless and therefore contained inserts. Screening of
106 independent phage clones with affinity-purified anti-TdT
antibody and 1251-protein A resulted in 25 positive clones
(0.0025%).
To demonstrate that the reactivity of the phage clones
with the antibody probe was due to antigenic determinants
on the cDNA translation product, four of the clones were
tested to determine if the t3-galactosidase-cDNA fusion pro-
tein bound the antibody. Such a protein is larger than most
other E. coli proteins and is readily visible after electropho-
retic separation of the lysogen proteins. The proteins were
visualized by transferring to nitrocellulose paper and probing
with anti-TdT antibody followed by treatment with 1 51-pro-
tein A. For this experiment, protein lysates from lysogens
induced by temperature shift and either induced or unin-
duced with iPrSGalp were analyzed. Temperature shift inac-
tivates the c1857 X repressor, causing replication of the pro-
virus and partial derepression of the f3galactosidase-cDNA
fusion protein. Addition of iPrSGalp fully derepresses the
system, allowing maximal fusion protein synthesis. The
wild-type Xgtll lysogen showed no specific bands with or
without i-PrSGalp (Fig. 1, lane gt) even though the major pro-
tein in iPrSGalp-induced lysates was ,Bgalactosidase (not
shown). Clone 3 and clone 12 showed a specific band migrat-
ing slightly slower than f3galactosidase. Clone 18 and clone
20 showed no specific bands. The absence of a specific band
in clone 20 is surprising because, as shown below and dis-
cussed later, the cDNA in this clone overlapped in sequence
with that of clone 3. These results show that in at least two of
four cases, the antibody recognized the cDNA translation
product and not a phage or bacterial protein.
Six of the clones giving the strongest signals with the anti-
body probe were compared to each other for nucleic acid
sequence homology. The cDNA insert from XTdT20 was
cloned into pBR322, and the plasmid, pTdT20, was used to
3 12 18 20 gt
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FiG. 1 Specific binding of anti-TdT antibody to the 8-galacto-
sidase-cDNA fusion protein synthesized by Xgtll clones indicated
at the top of the lanes. Xgt11 clones detected by antibody screening
were lysogenized in lacd" E. coli. Lysogens were grown at 370C,
shifted to 450C, and then uninduced (-) or induced (+) with iPrS-
Galp. Lysogen proteins were fractionated by electrophoresis
through 7% NaDodSO4/polyacrylamide gels, transferred to nitro-
cellulose, and hybridized to anti-TdT antibody followed by treat-
ment with 1151-protein-A. Exposure was for 12 hr at -70'C with an
intensifying screen. Lysogens shown above were constructed from
phage clones 3, 12, 18, and 20 and from wild-type Xgtll (lane gt).
The position of ,B-galactosidase (/-Galase) was determined from the
mobility of purified P-galactosidase on an identical gel stained with
Coomassie blue.
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FIG. 2. Hybridization of pTdT20 to cDNA inserts of Xgtll
clones detected by antibody screening. DNA from phage clones was
digested with restriction enzyme EcoRI to excise the cDNA inserts,
separated by electrophoresis on 1.4% agarose, and transferred to
nitrocellulose. The filter was hybridized to 32P-labeled pTdT20, a
plasmid which contains the cDNA insert of phage 20 cloned into the
EcoRI site of pBR322. Lanes: phage clones 3, 10, 12, 18, 20, and 21,
linearized pBR322 (lane p), and HindIll-cleaved phage X DNA (lane
X).
probe the six phage cDNA inserts (Fig. 2). The probe hybrid-
ized to four of six cDNA inserts and to control pBR322
DNA. pTdT20 hybridized to its cognate 950-bp fragment, to
the 450-bp insert of clones 3 and 12, and to the 1000-bp insert
of clone 21. No insert from clone 10 could be seen on exami-
nation of the ethidium bromide staining of the agarose gel
(not shown). Phage clone 21 grew poorly (not shown). Clone
18 showed a 1600-bp insert; however, its insert did not hy-
bridize to the probe. Therefore, these three clones were not
studied further. (High molecular weight bands that hybrid-
ized to the probe represented uncleaved phage DNA.) The
insert bands were not derived from phage DNA since the
pTdT20 probe did not hybridize to X phage DNA, as shown
by the absence of bands in HindIII-cleaved X DNA (Fig. 2,
lane X). These results indicate that at least four out of six
clones identified by the polyclonal antibody were derived
from a single mRNA species.
Because the pTdT20 clone was identified only by antibody
binding, there was no assurance that it represented TdT. To
determine the authenticity of pTdT20, we first investigated
the correlation of the presence of mRNA hybridizing to the
clone with TdT enzyme and protein levels in various cell
lines and in thymus tissue. Both RLd11 cells and thymus,
which express TdT protein as determined by both immuno-
precipitation and enzymatic activity (4, 14), contained a sin-
gle 2200-nucleotide mRNA that hybridized to the probe (Fig.
3). In contrast, two cell types that lack TdT, fibroblasts (L
cells; not shown) and myelomas (represented by the ARS
hybridoma in Fig. 3), showed no detectable pTdT20-related
mRNA even after 10-fold longer exposure of the autoradio-
gram. The most telling comparison was between two Abel-
son murine leukemia virus-transformed cell lines that rear-
range their heavy chain loci and, therefore, are at the same
FIG. 3. Differential expression of mRNA hybridizing to pTdT20
in mouse cell lines and thymus tissue. Poly(A)-containing RNA was
separated by electrophoresis through 1.2% agarose in the presence
of formaldehyde. The RNA was transferred to nitrocellulose and
probed with 32P-labeled pTdT20. Size markers were 28S and 18S
ribosomal RNA and tubulin mRNA (1800 bp) detected by subse-
quent hybridization to a rat tubulin cDNA probe. The presence (+)
or absence (-) of TdT in cells as assayed by immunoprecipitation
and enzymatic activity is indicated. Lanes: 22D6 and 40E4, Abelson
murine leukemia virus-transformed pre-B-cell lines 22D6 (10 fig) and
40E4 (10 Mg); ARS, B-cell hybridoma ARS (10 Mtg); RL (in order),
BALB/c thymoma RLM11 (6 Mg) and RLd 11 (10 Mg); and BALB/c
thymus (6 Mg).
stage of pre-B-lymphocyte differentiation (32). Cell line
40E4 expressed TdT as assayed in both enzymatic activity
and immunoprecipitation with anti-TdT antibody; the other
cell line, 22D6, was negative by both assays (unpublished
data). The 40E4 cell line expressed the 2200-nucleotide TdT
mRNA, while the 22D6 cell line did not. Because the two
transformants are nearly identical in their stage of differenti-
ation, the correlation of enzyme level with the 2200-nucleo-
tide mRNA strongly supports the identity of the cDNA clone
as TdT.
To demonstrate that the nucleotide sequence of pTdT20 is
complementary to that of TdT mRNA, hybrid selection of
mRNA using the plasmid DNA was employed. To show the
electrophoretic mobility of in vivo synthesized TdT, cells
from the mouse thymoma cell line RL 9 3 were metabolically
labeled with [35S]methionine. Lysates of the labeled cells
were immunoprecipitated with normal rabbit serum or anti-
TdT antibody (Fig. 4, lanes 1 and 2). A protein of Mr 58,000
was specifically immunoprecipitated by the anti-TdT anti-
body. It has been shown previously that such an antiserum
precipitates a protein of this size that has TdT enzymatic
activity and corresponds to the full-length protein (14). The
specifically immunoprecipitated in vitro translation product
(Fig. 4, lanes 3 and 4) comigrated with the protein specifical-
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FIG. 4. Immunoprecipitation with anti-TdT antibody of in vitro
translated protein products from RLU11 mRNA specifically hybrid-
izing to pTdT20. Lysates of [35S]methionine-labeled proteins from
RL Y 3 cells were immunoprecipitated with normal rabbit serum or
anti-TdT antibody (lanes 1 and 2). Poly(A)-containing RNA from
RLd 11 cells was translated in a reticulocyte lysate system and im-
munoprecipitated with normal rabbit serum or anti-TdT antibody
(lanes 3 and 4). RLd 11 RNA was hybridized to filter-bound
pTdT20, pBR322, or a rat tubulin cDNA-containing plasmid (lanes
5, 6, and 7, respectively). Bound RNA was eluted and translated,
and the protein products were then immunoprecipitated with anti-
TdT antibody.
ly immunoprecipitated from metabolically labeled thymoma
cells. When RLcT11 RNA was first hybridized to filters to
which was bound pTdT20 DNA, eluted, and then translated,
the only translation product found that was not in the control
sample was the Mr 58,000 band (Fig. 4, lane 5). By contrast,
when a tubulin cDNA plasmid or pBR322 DNA was bound
to the filter and similarly processed, no specific band was
detectable (Fig. 4, lanes 6 and 7). Therefore, the plasmid
pTdT20 specifically hybridizes to an mRNA that directs the
translation of TdT protein. To determine the approximate
amount ofDNA in the mouse genome that could hybridize to
the TdT cDNA clone, mouse liver DNA was cleaved with
the infrequent cutting restriction enzymes BamHI or Pst I,
fractionated by agarose gel electrophoresis, and transferred
to nitrocellulose. To detect as much TdT-encoding genomic
DNA as possible, a longer TdT cDNA clone was obtained by
screening a cDNA library constructed from the thymoma
cell line EL4, with a pTdT20 probe. This cDNA clone,
pOK6, contains a 1400-bp insert that begins at the 3' poly(A)
tail of the mRNA and encompasses the entire nucleotide se-
quence of the pTdT20 insert (not shown). The cDNA insert
from pOK6 was labeled by nick-translation and hybridized
to the filter (Fig. 5). An autoradiogram of the filter showed,
with BamHI digestion, bands at 20, 10, and 3 kb and, with
Pst I digestion, bands at 15, 6, and 3.8 kb. Because there was
only a small number of genomic DNA restriction fragments
homologous to pOK6, it appears likely that there is only one
or possibly a few genes in mouse that are related to the
probe.
DISCUSSION
By using a method capable of identifying rare cDNA clones,
it has been possible to clone a cDNA representation of TdT
aw__-6.4
-4.2
FIG. 5. Mouse genomic DNA
-2..t.'probed with pOK6. DNA isolated
from C57BI/6 thymoma cell line
- 1.8 EL4 (10 /ig) was digested to com-
pletion with restriction enzymes
%ilti^+ BamHI (lane 1) or Pst I (lane 2),fractionated by electrophoresis
_ through L.0o agarose, and trans-
ferred to nitrocellulose. The filter
was hybridized to the TdT cDNA
clone, pOK6. X-ray film was ex-
posed for 2 days at -700C with an
intensifying screen.
mRNA. The cloned DNA hybridized to a single 2200-nucleo-
tide mRNA in those B- and T-lymphoid cells that contain the
enzyme. Those cells tested that lacked TdT also lacked the
mRNA. Thus, TdT expression in these cell lines appears to
be regulated at the mRNA level, presumably by modulation
of transcription. Only a few genomic DNA restriction frag-
ments hybridized to the TdT cDNA clone, suggesting that
TdT is not a member of a multi-gene family. The size of
mRNA found in various cells and the small amount of TdT-
related DNA suggests that the TdT in B- and T-lymphoid
cells could be encoded by the same gene. Therefore, TdT
would represent a gene selectively expressed in both imma-
ture B- and T-lymphoid cells but not in mature cells, making
it interesting to further study its regulation. The selective
expression of the TdT gene early in B- and T-lymphoid cell
differentiation is consistent with its postulated role of insert-
ing the N region into DNA joins.
The frequency of TdT mRNA molecules can be estimated
from the percentage of positive clones detected by antibody
screening of the Xgtll cDNA library (0.0025%), but it is first
necessary to consider the efficiency of the antibody screen-
ing procedure. When inserted into the EcoRI site of Xgtll,
one out of six cDNA molecules should be in the appropriate
phase and orientation to allow translation of f-galactosidase.
Assuming that antibody screening is perfectly efficient, 6 x
0.0025% or 0.015% of the Xgtll phage in the cDNA library
should contain inserts. In fact, rescreening the library with a
radioactive pTdT20 probe showed that 0.01% of the clones
were positive (data not shown). Thus, the antibody screen-
ing procedure detected most in-phase TdT cDNA-containing
clones. These data show that about 10-4 of the mRNA mole-
cules in RLc6 11 cells encode TdT, and it is evident that the
antibody screening could easily detect a mRNA of this abun-
dance or even less. This sensitivity underscores the power of
the Xgtll system when used with a polyclonal antibody.
The antibody probe recognized the P-galactosidase-cDNA
fusion protein in the phage plaques of each positive clone. It
was surprising then that the fusion protein synthesized by
the phage whose cDNA insert was used most extensively in
these studies, phage 20, showed no reactivity with antibody
after electrophoretic fractionation and transfer to nitrocellu-
Immunology: Landau et aL
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lose. However, the p-galactosidase-cDNA fusion proteins
synthesized by phage 3 and phage 12, whose nucleotide se-
quences overlapped with that of phage 20, bound the anti-
body. This discrepancy may indicate a general precaution
that should be taken when comparing results obtained by
antibody screening of phage plaques with those obtained by
blotting of protein that has been fractionated by
NaDodSO4/polyacrylamide gel electrophoresis. In the for-
mer case, protein is bound to nitrocellulose without prior de-
naturation; in the latter case, proteins are denatured by boil-
ing in NaDodSO4 and 2-mercaptoethanol prior to electro-
phoresis and transfer to nitrocellulose. In some cases,
protein bound to nitrocellulose after such processing may
not present antigenic determinants available for antibody
binding, possibly because of improper renaturation of the
protein after transfer to the filter.
Although it is not unambiguously proven here that the pro-
tein translated in the hybrid selection experiment was TdT
and not a protein against which there is contaminating activi-
ty in the antiserum, there are several arguments strongly fa-
voring its identity as TdT. First, the antibody was prepared
against the low molecular weight form of TdT, which would
not likely be contaminated with significant amounts of a Mr
58,000 protein. Second, binding of purified low molecular
weight TdT to the antibody before immunoprecipitation
abolished the ability of the antibody to immunoprecipitate
the Mr 58,000 band (unpublished observations; ref. 18).
Thus, those antibodies that bound purified TdT also bound
the Mr 58,000 band. Third, the mRNA encoding the postulat-
ed contaminant would have to show a cell type-specific
expression identical to that of TdT. In the case of cell lines
40E4 and 22D6, such specificity would be particularly un-
likely, given the relatedness of the two cell lines. In fact, it is
not at all clear why two cell lines of such similar properties
should differ so markedly in their TdT content.
The TdT cDNA should be used to facilitate understanding
of the expression and structure of the gene for TdT. In addi-
tion, introduction of a functional TdT gene into cells should
provide insights into the role of TdT in lymphocyte matura-
tion.
This work was supported by American Cancer Society Grant IM-
355 to D.B., National Cancer Institute Grant CA14051 (core grant to
S. E. Luria), National Cancer Institute Grant CA22599 and Ameri-
can Cancer Society Grant CH256 to A.E.S., and National Institutes
of Health Grant A118162 to I.L.W.
1. Krakow, J. S., Coutsogeorgopoulos, C. & Canellakis, E. S.
(1962) Biochim. Biophys. Acta 55, 639-650.
2. Kato, K., Goncalves, J. M., Houts, G. E. & Bollum, F. J.
(1967) J. Biol. Chem. 242, 2780-2789.
3. Bollum, F. J. (1974) in The Enzymes, ed. Boyer, P. D. (Aca-
demic, New York), Vol. 10, pp. 145-171.
4. Chang, L. M. S. (1971) Biochem. Biophys. Res. Commun. 44,
124-131.
5. Kung, P. C., Silverstone, A. E., McCaffrey, R. P. & Balti-
more, D. (1975) J. Exp. Med. 141, 855-865.
6. McCaffrey, R. P., Harrison, T. A., Parkman, R. & Baltimore,
D. (1975) N. Engl. J. Med. 292, 775-780.
7. Rothenberg, E. & Triglia, D. (1983) J. Immunol. 130, 1627-
1633.
8. Silverstone, A. E., Cantor, H., Goldstein, G. & Baltimore, D.
(1976) J. Exp. Med. 144, 543-550.
9. Pierce, J. H. & Aaronson, S. A. (1982) J. Exp. Med. 156, 873-
887.
10. Boss, M., Greaves, M. & Teich, N. (1979) Nature (London)
278, 551-553.
11. Coleman, M. S., Hutton, J. J., DeSimone, P. & Bollum, F. J.
(1974) Proc. Natl. Acad. Sci. USA 71, 4404 4407.
12. Yoneda, M. & Bollum, F. J. (1%5) J. Biol. Chem. 240, 3385-
3391.
13. Chang, L. M. S. & Bollum, F. J. (1971) J. Biol. Chem. 246,
909-916.
14. Silverstone, A., Sun, L., Witte, 0. N. & Baltimore, D. (1980)
J. Biol. Chem. 255, 791-7%.
15. Bollum, F. J. & Brown, M. (1979) Nature (London) 278, 191-
192.
16. Nakamura, H., Tanabe, K., Yoshida, S. & Morita, T. (1981) J.
Biol. Chem. 256, 8745-8751.
17. Chang, L. M. S., Plevani, P. & Bollum, F. J. (1982) J. Biol.
Chem. 257, 5700-5706.
18. Wolf, S. C., Kourides, I. A., Good, R. A. & Silverstone,
A. E. (1982) J. Biol. Chem. 257, 4013-4015.
19. Baltimore, D. (1974) Nature (London) 248, 409-411.
20. Gearhardt, P. J., Johnson, N. D., Douglas, R. & Hood, L.
(1982) Nature (London) 291, 29-33.
21. Bothwell, A. L. M., Paskind, M., Reth, M., Imanishi-Kari, T.,
Rajewsky, K. & Baltimore, D. (1981) Cell 24, 625-637.
22. Alt, F. W. & Baltimore, D. (1982) Proc. Natl. Acad. Sci. USA
79, 4118-4122.
23. Hedrick, S. M., Nielsen, E. A., Kavaler, J., Cohen, D. I. &
Davis, M. M. (1984) Nature (London) 308, 153-158.
24. Young, R. A. & Davis, R. W. (1983) Proc. Natl. Acad. Sci.
USA 80, 1194-1198.
25. Huynh, T. V., Young, R. A. & Davis, R. W. (1984) in DNA
Cloning Techniques: A Practical Approach, ed. Glover, D.
(IRL, Oxford), in press.
26. Bittner, M., Kupferer, P. & Morris, C. F. (1980) Anal. Bio-
chem. 102, 459-471.
27. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J. & Rutter,
W. J. (1979) Biochemistry 18, 5294-5299.
28. Alt, F. W., Enea, V., Bothwell, A. L. M. & Baltimore, D.
(1980) Cell 21, 1-12.
29. Okayama, H. & Berg, P. (1982) Mol. Cell. Biol. 2, 161-170.
30. Ellis, R. W., Hopkins, N. & Fleissner, E. (1980) J. Virol. 33,
661-670.
31. Silverstone, A. E., Rosenberg, N., Baltimore, D., Sato, V. L.,
Scheid, M. P. & Boyse, E. A. (1978) in Differentiation ofNor-
mal and Neoplastic Hematopoietic Cells, eds. Clarkson, B.,
Till, J. & Marks, P. (Cold Spring Harbor Laboratory, Cold
Spring Harbor, NY), pp. 443-453.
32. Alt, F., Rosenberg, N., Lewis, S., Thomas, E. & Baltimore,
D. (1981) Cell 27, 381-390.
Proc. NatL Acad Sci. USA 81 (1984)
